Valuation: OneSource Specialty Pharma Limited

Market Cap 183B 1.92B 1.67B 1.56B 1.42B 2.68B 2.72B 18.28B 7.16B 91.75B 7.22B 7.06B 306B P/E 2026
-229x
P/E 2027 * 39.5x
Enterprise Value 194B 2.04B 1.76B 1.65B 1.51B 2.83B 2.88B 19.36B 7.59B 97.16B 7.64B 7.48B 324B EV / Sales 2026
12.7x
EV / Sales 2027 * 8.82x
Free-Float
61.97%
Yield 2026 *
-
Yield 2027 * -
1 day-3.73%
1 week-0.93%
Current month-4.97%
1 month-8.00%
3 months-15.90%
6 months+27.07%
Current year-14.99%
1 week 1,530.1
Extreme 1530.1
1,647
1 month 1,506.7
Extreme 1506.7
1,755.2
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-29
Director of Finance/CFO - 2024-07-03
Compliance Officer - 2023-03-13
Director TitleAgeSince
Director/Board Member 65 2021-04-06
Director/Board Member 54 2024-02-29
Director/Board Member 66 2025-02-26
Change 5-day change 1-year change 3-year change Capi.($)
-3.73%-0.93%-18.99% - 1.92B
-2.21%+0.32%+3.15%+13.96% 49.54B
+1.26%+5.14%+488.34%+591.50% 44.06B
-0.20%+8.74%+23.63%+74.48% 40.85B
-1.13%+1.99%+29.49%+9.37% 40.14B
+4.73%+13.29%+27.76%+54.22% 34.17B
-1.49%+2.27%+30.87%+126.29% 16.9B
+0.45%+3.52% - - 16.78B
-0.92%-0.69%+3.62%+20.01% 14B
+0.26%+8.81%+85.72%+30.79% 13.46B
Average -0.36%+7.42%+74.84%+115.08% 27.18B
Weighted average by Cap. +0.04%+7.37%+103.74%+137.69%

Financials

2026 2027 *
Net sales 13.41B 141M 122M 114M 104M 196M 199M 1.34B 524M 6.71B 528M 517M 22.4B 21.8B 229M 198M 185M 169M 318M 324M 2.17B 852M 10.91B 858M 839M 36.4B
Net income -1.19B -12.48M -10.82M -10.12M -9.24M -17.38M -17.68M -119M -46.51M -596M -46.86M -45.84M -1.99B 4.46B 46.75M 40.51M 37.93M 34.61M 65.12M 66.22M 445M 174M 2.23B 176M 172M 7.45B
Net Debt 10.81B 113M 98.19M 91.92M 83.87M 158M 160M 1.08B 422M 5.41B 425M 416M 18.05B 8.86B 92.85M 80.46M 75.33M 68.73M 129M 132M 883M 346M 4.43B 349M 341M 14.79B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
26-08-12 1,539.20 -3.73% 135,574
26-08-11 ₹1,598.90 +1.49% 356,777
26-08-10 ₹1,575.40 -0.04% 230,127
26-08-07 ₹1,576.00 +1.21% 151,582
26-08-06 ₹1,557.10 +0.22% 200,704
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,598.90INR
Average target price
2,056.00INR
Spread / Average Target
+28.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock